Canigen CPV2b
Department: Baker Institute for Animal Health
Inventor: Colin Parrish, Leland Carmichael
Canigen CPV2b is a vaccine comprised of live attenuated canine parvovirus 2b Strain CPV39 and is approved for use in puppies from the age of five weeks to induce protection against CPV serotypes 2b, 2a and 2.